These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10430335)

  • 1. Diminished interferon-gamma production in gastric mucosa T lymphocytes after H. pylori eradication in duodenal ulcer patients.
    Ihan A; Tepez B; Gubina M; Malovrh T; Kopitar A
    Hepatogastroenterology; 1999; 46(27):1740-5. PubMed ID: 10430335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Il-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients.
    Ihan A; Tepez B; Kavcic I; Gubina M
    Hepatogastroenterology; 1996; 43(12):1665-70. PubMed ID: 8975986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished Th1-type cytokine production in gastric mucosa T-lymphocytes after H. pylori eradication in duodenal ulcer patients.
    Ihan A; Tepes B; Gubina M
    Pflugers Arch; 2000; 440(5 Suppl):R89-90. PubMed ID: 11005624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
    Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
    Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo.
    Rad R; Brenner L; Bauer S; Schwendy S; Layland L; da Costa CP; Reindl W; Dossumbekova A; Friedrich M; Saur D; Wagner H; Schmid RM; Prinz C
    Gastroenterology; 2006 Aug; 131(2):525-37. PubMed ID: 16890606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished Th1-type cytokine production in gastric mucosa T lymphocytes after H. pylori eradication in duodenal ulcer patients.
    Ihan A; Tepes B; Gubina M
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R089-R090. PubMed ID: 28008493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased interleukin-10 in Helicobacter pylori infection could be involved in the mechanism protecting from allergy.
    Oderda G; Vivenza D; Rapa A; Boldorini R; Bonsignori I; Bona G
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):301-5. PubMed ID: 17873741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer.
    Itoh T; Seno H; Kita T; Chiba T; Wakatsuki Y
    Scand J Gastroenterol; 2005 Jun; 40(6):641-7. PubMed ID: 16036523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
    Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L
    Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
    Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
    Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
    Kozlova IV; Eliseev IuIu; Pakhomova AL; Khan SA
    Klin Med (Mosk); 2005; 83(7):52-5. PubMed ID: 16117427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.